OCLASSEN GLENN A 4
4 · Transcept Pharmaceuticals Inc · Filed Sep 20, 2011
Insider Transaction Report
Form 4
OCLASSEN GLENN A
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2011-09-19$5.80/sh+10,000$58,000→ 310,800 total - Purchase
Common Stock
2011-09-19$5.80/sh+10,000$58,000→ 73,457 total(indirect: See Footnote)
Footnotes (1)
- [F1]Shares held directly by the Reporting Person's spouse.